We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
-11.85%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$2.07B
AUM Growth
+$253M
Cap. Flow
+$528M
Cap. Flow %
25.51%
Top 10 Hldgs %
62.26%
Holding
297
New
23
Increased
108
Reduced
98
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 4.94%
2 Financials 1.93%
3 Communication Services 1.27%
4 Healthcare 1.04%
5 Consumer Staples 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
51
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$5.12M 0.25%
122,989
+7,953
+7% +$343K
GOOG icon
52
Alphabet (Google) Class C
GOOG
$4.22T
$5.03M 0.24%
45,980
+3,820
+9% +$451K
EEM icon
53
iShares MSCI Emerging Markets ETF
EEM
$28B
$4.75M 0.23%
118,519
+13,182
+13% +$553K
VNQ icon
54
Vanguard Real Estate ETF
VNQ
$39.6B
$4.59M 0.22%
50,347
+15,424
+44% +$1.54M
PG icon
55
Procter & Gamble
PG
$349B
$4.29M 0.21%
29,861
-1,133
-4% -$170K
JNJ icon
56
Johnson & Johnson
JNJ
$609B
$4.23M 0.2%
23,859
-848
-3% -$151K
SCHX icon
57
Schwab US Large- Cap ETF
SCHX
$71.7B
$4.17M 0.2%
280,122
-4,941
-2% -$80.1K
FNDF icon
58
Schwab Fundamental International Large Company Index ETF
FNDF
$24.2B
$4.13M 0.2%
146,014
+13,163
+10% +$403K
SCZ icon
59
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.9B
$4.09M 0.2%
74,816
+3,541
+5% +$214K
EFA icon
60
iShares MSCI EAFE ETF
EFA
$76.5B
$3.49M 0.17%
55,933
+4,936
+10% +$336K
PEP icon
61
PepsiCo
PEP
$187B
$3.35M 0.16%
20,127
-978
-5% -$165K
EEMV icon
62
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.42B
$3.13M 0.15%
56,400
+107
+0.2% +$6.18K
RY icon
63
Royal Bank of Canada
RY
$299B
$3.13M 0.15%
32,315
AOM icon
64
iShares Core Moderate Allocation ETF
AOM
$1.77B
$2.9M 0.14%
74,511
-107,202
-59% -$4.33M
BRK.A icon
65
Berkshire Hathaway Class A
BRK.A
$1.06T
$2.86M 0.14%
7
VONV icon
66
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$2.76M 0.13%
+43,384
New +$2.98M
IYY icon
67
iShares Dow Jones US ETF
IYY
$2.94B
$2.75M 0.13%
29,744
BSV icon
68
Vanguard Short-Term Bond ETF
BSV
$44.7B
$2.72M 0.13%
35,412
+11,399
+47% +$878K
JPM icon
69
JPMorgan Chase
JPM
$907B
$2.72M 0.13%
24,136
+975
+4% +$121K
AMZN icon
70
Amazon
AMZN
$2.66T
$2.69M 0.13%
25,340
+4,720
+23% +$591K
IWR icon
71
iShares Russell Mid-Cap ETF
IWR
$56.6B
$2.67M 0.13%
41,246
+1,087
+3% +$77.4K
VCSH icon
72
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$2.64M 0.13%
34,581
+785
+2% +$60.3K
VUG icon
73
Vanguard Growth ETF
VUG
$221B
$2.61M 0.13%
70,182
+192
+0.3% +$7.89K
ABBV icon
74
AbbVie
ABBV
$450B
$2.54M 0.12%
16,614
+55
+0.3% +$8.4K
USB icon
75
US Bancorp
USB
$98.4B
$2.38M 0.11%
51,701
+2,879
+6% +$144K

Similar funds

Aspiriant LLC's Q2 2022 Portfolio in Review

As of Q2 2022, Aspiriant LLC held 297 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Aspiriant LLC deployed $528M of net new capital in Q2 2022, opening 23 new positions and adding to 108 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, down from 9.5% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares Core Moderate Allocation ETF, an estimated $4.33M trimmed.

  • Aspiriant LLC's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.
  • Aspiriant LLC added most to Vanguard Tax-Exempt Bond Index Fund in Q2 2022, an estimated $267M increase.
  • Aspiriant LLC's biggest Q2 2022 reduction was iShares Core Moderate Allocation ETF, cutting an estimated $4.33M.
  • Aspiriant LLC fully exited Leidos in Q2 2022, selling an estimated $14.6M.
  • Aspiriant LLC's ten largest holdings make up 62% of its $2.07B portfolio in Q2 2022.
  • Aspiriant LLC opened 23 new positions and closed 23 in Q2 2022.
  • Aspiriant LLC's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.